PALIPERIDONE PALMITATE 6-MONTH FORMULATION FOR THE TREATMENT OF SCHIZOPHRENIA: A 4-MONTH FOLLOW-UP STUDY

被引：0
|
作者：
Romero Guillena, S. L. [1 ]
Rodriguez Menendez, G. [1 ]
Florido Puerto, A. I. [1 ]
Fernandez Flores, A. S. [1 ]
机构：
[1] UGC Salud Mental Virgen Macarena, Psychiat, Seville, Spain
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.2308
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV1014
引用
收藏
页码：S1086 / S1087
页数：2
相关论文
共 50 条
  • [1] Paliperidone palmitate 6-month formulation for the treatment of schizophrenia: a 14-month follow-up study
    Romero Guillena, S. L.
    Marin Mateos, H.
    Rodriguez Menendez, G.
    [J]. EUROPEAN PSYCHIATRY, 2024, 67 : S752 - S752
  • [2] Paliperidone palmitate 3 month formulation for the treatment of schizophrenia: a 36 months follow-up study
    Romero Guillena, S. L.
    Plasencia Garcia De Diego, B. O.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S548 - S548
  • [3] Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
    Cirnigliaro, Giovanna
    Battini, Vera
    Castiglioni, Michele
    Renne, Marica
    Mosini, Giulia
    Cheli, Stefania
    Carnovale, Carla
    Dell'Osso, Bernardo
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (04) : 325 - 332
  • [4] Rivastigmine for the treatment of cognitive impairment in residual schizophrenia: A 6-month follow-up
    Lenzi, A
    Maltinti, E
    Tiano, L
    Manca, E
    Spagna, F
    Coli, E
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S321 - S321
  • [5] LONG-TERM FOLLOW-UP OF A CLINICAL-TRIAL OF 6-MONTH AND 4-MONTH REGIMENS OF CHEMOTHERAPY IN THE TREATMENT OF PULMONARY TUBERCULOSIS
    FOX, W
    SENG, TT
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (05): : 779 - 783
  • [6] Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
    Turkoz, Ibrahim
    Wong, Joshua
    Chee, Benjamin
    Siddiqui, Uzma
    Knight, R. Karl
    Richarz, Ute
    Correll, Christoph U.
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
  • [7] The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia
    Bioque, Miquel
    Bernardo, Miquel
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (14) : 1623 - 1629
  • [8] Therapeutic adherence and readmissions in schizophrenic patients treated with paliperidone a 6-month follow-up
    Blanco, J. A.
    Aguado, J. A.
    Medina, G.
    Segurado, O.
    Franch, J. I.
    Madrigal, J. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S526 - S526
  • [9] Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study
    Durand, Eric
    Lemitre, Mathilde
    Couty, Ludovic
    Sharkawi, Tahmer
    Brasselet, Camille
    Vert, Michel
    Lafont, Antoine
    [J]. EUROINTERVENTION, 2012, 8 (02) : 242 - 249
  • [10] A retrospective study of pharmacological treatment in anorexia nervosa: 6-month and 12-month follow-up
    Chiu, Huei-Ping
    Huang, Min-Wei
    Tsai, Shr-Yu
    Hsu, Chiann-Yi
    [J]. BMC PSYCHIATRY, 2023, 23 (01)
12345